These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9298352)

  • 21. Comparison of three immunoassays for CA 19-9.
    Hotakainen K; Tanner P; Alfthan H; Haglund C; Stenman UH
    Clin Chim Acta; 2009 Feb; 400(1-2):123-7. PubMed ID: 19038241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
    Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer.
    Gemer O; Lurian M; Gdalevich M; Kapustian V; Piura E; Schneider D; Lavie O; Levy T; Fishman A; Dgani R; Levavi H; Beller U
    Eur J Surg Oncol; 2005 Nov; 31(9):1006-10. PubMed ID: 16005601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems.
    Lestin M; Hergert M; Lestin HG; Brinker C; Storm H; Kuhrt E; Kuhrt B; Lambrecht HG; Kühnel W
    Clin Lab; 2002; 48(3-4):211-21. PubMed ID: 11934224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two sensitive immunometric assays for serum thyroid stimulating hormone evaluated.
    Papadea C; Papadea NA; Cate JC; Didyk RB
    Ann Clin Lab Sci; 1998; 28(2):88-98. PubMed ID: 9558447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients].
    ławicki S; Czygier M; Gacuta-Szumarska E; Knapp P; Szmitkowski M
    Pol Merkur Lekarski; 2006 Nov; 21(125):465-8. PubMed ID: 17345841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a new D-dimer microparticle enzyme immunoassay (AxSYM D-Dimer) in patients with suspected pulmonary embolism (PE).
    Ghanima W; Sandset PM
    Thromb Res; 2007; 120(4):471-6. PubMed ID: 17161451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Validity of immunochemical assays for blood estradiol. Study conducted in 1994].
    Patricot MC; Badonnel Y; Bugugnani MJ; Collignon I; Delvigne L; Lacroix I; Mathian B
    Ann Biol Clin (Paris); 1995; 53(7-8):399-406. PubMed ID: 8597310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance characteristics of seven automated CA 125 assays.
    Mongia SK; Rawlins ML; Owen WE; Roberts WL
    Am J Clin Pathol; 2006 Jun; 125(6):921-7. PubMed ID: 16690492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients.
    van Dalen A; Favier J; Baumgartner L; Hasholzner U; de Bruijn H; Dobbler D; Dombi VH; Fink D; Giai M; McGing P; Harlozinska A; Kainz C; Markowska J; Molina R; Sturgeon C; Einarsson R
    Anticancer Res; 1999; 19(4A):2523-6. PubMed ID: 10470187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI.
    Kim HS; Kim JW; Cho JY; Chung HH; Park NH; Song YS; Kim SH; Kang SB
    Eur J Surg Oncol; 2009 Aug; 35(8):870-6. PubMed ID: 19179039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
    Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of time-resolved fluorometric immunoassay of CA 50].
    Hara K; Mitsuhashi F; Sakawaki T; Ohkura H
    Rinsho Byori; 1989 Jul; 37(7):789-94. PubMed ID: 2691736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative predictors for residual tumor after surgery in patients with ovarian carcinoma.
    de Jong D; Eijkemans MJ; Lie Fong S; Gerestein CG; Kooi GS; Baalbergen A; van der Burg ME; Burger CW; Ansink AC
    Oncology; 2007; 72(5-6):293-301. PubMed ID: 18198490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of one first and three second generation methods for the determination of CA 125.
    Martin M; Blockx P
    Anticancer Res; 1997; 17(4B):3171-5. PubMed ID: 9329629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of five immunoassay procedures for the ovarian carcinoma-associated antigenic determinant CA 125 in serum.
    Yedema KA; Thomas CM; Segers MF; Doesburg WH; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 1992 Dec; 47(3):245-52. PubMed ID: 1294413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies.
    Stephan C; Kramer J; Meyer HA; Kristiansen G; Ziemer S; Deger S; Lein M; Loening SA; Jung K
    BJU Int; 2007 Jun; 99(6):1427-31. PubMed ID: 17355366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of five commercial kits for free thyroxine estimation by comparison with equilibrium dialysis method in nonthyroidal illness.
    Chailurkit LO; Rajatanavin R; Teerarungsikul K
    J Med Assoc Thai; 1996 Oct; 79(10):661-6. PubMed ID: 8997002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary.
    Ødegaard E; Davidson B; Elgaaen BV; Fagerhol MK; Engh V; Onsrud M; Staff AC
    Am J Obstet Gynecol; 2008 Apr; 198(4):418.e1-7. PubMed ID: 18241816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma.
    Olawaiye AB; Rauh-Hain JA; Withiam-Leitch M; Rueda B; Goodman A; del Carmen MG
    Gynecol Oncol; 2008 Sep; 110(3):293-8. PubMed ID: 18644620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.